2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one

C137H164N22O31S6 — CID 160536997

About 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one

2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one (PubChem CID 160536997) has the molecular formula C137H164N22O31S6 and a molecular weight of 2807.34 g/mol. Its IUPAC name is 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one.

Molecular Properties

• Compound Name: 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one
• PubChem CID: 160536997
• Molecular Formula: C137H164N22O31S6
• Molecular Weight: 2807.34 g/mol
• Exact Mass: 2805.03
• IUPAC Name: 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one
• SMILES: COc1ccccc1[C@H](CN1c2nc(-c3ncco3)n(C)c2C(=O)N(CCc2ncco2)S1(=O)=O)OC1CCOCC1.COc1ccccc1[C@H](CN1c2sc(-c3ncco3)c(C)c2C(=S)N(C(C)(C)C(C)=O)S1(=O)=O)OC(C)C.COc1ccccc1[C@H](Cc1nn(C(C)(C)C(=O)O)c(=O)c2c1nc(-c1ncco1)n2C)OC1CCCCC1.COc1ccccc1[C@H](Cc1nn(C(C)(C)C(N)=O)c(=O)c2c1nc(C1CCC1)n2C)OC1CCCCC1.COc1ccccc1[C@H](Cc1nn(CCS(C)(=O)=O)c(=O)c2c(C)c(-c3ncco3)sc12)OC1CCOCC1
• InChI: InChI=1S/C29H39N5O4.C28H33N5O6.C27H30N6O8S.C27H31N3O7S2.C26H31N3O6S3/c1-29(2,28(30)36)34-27(35)25-24(31-26(33(25)3)18-11-10-12-18)21(32-34)17-23(38-19-13-6-5-7-14-19)20-15-8-9-16-22(20)37-4;1-28(2,27(35)36)33-26(34)23-22(30-24(32(23)3)25-29-14-15-38-25)19(31-33)16-21(39-17-10-6-5-7-11-17)18-12-8-9-13-20(18)37-4;1-31-23-24(30-25(31)26-29-11-16-40-26)33(42(35,36)32(27(23)34)12-7-22-28-10-15-39-22)17-21(41-18-8-13-38-14-9-18)19-5-3-4-6-20(19)37-2;1-17-23-25(38-24(17)26-28-10-14-36-26)20(29-30(27(23)31)11-15-39(3,32)33)16-22(37-18-8-12-35-13-9-18)19-6-4-5-7-21(19)34-2;1-15(2)35-20(18-10-8-9-11-19(18)33-7)14-28-25-21(16(3)22(37-25)23-27-12-13-34-23)24(36)29(38(28,31)32)26(5,6)17(4)30/h8-9,15-16,18-19,23H,5-7,10-14,17H2,1-4H3,(H2,30,36);8-9,12-15,17,21H,5-7,10-11,16H2,1-4H3,(H,35,36);3-6,10-11,15-16,18,21H,7-9,12-14,17H2,1-2H3;4-7,10,14,18,22H,8-9,11-13,15-16H2,1-3H3;8-13,15,20H,14H2,1-7H3/t23-;2*21-;22-;20-/m00000/s1
• InChIKey: QWHAWXRVIMHLFW-PPQLDPOVSA-N
• XLogP: 20.51
• TPSA: 628.95 Ų
• H-Bond Donors: 2
• H-Bond Acceptors: 50
• Rotatable Bonds: 47
• Heavy Atoms: 196
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2807.34
LogP ≤ 5	20.51
H-Bond Donors ≤ 5	2
H-Bond Acceptors ≤ 10	50

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one?

The IUPAC name of 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one (CID 160536997) is 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one.

What is the SMILES notation for 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one?

The canonical SMILES for 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one is COc1ccccc1[C@H](CN1c2nc(-c3ncco3)n(C)c2C(=O)N(CCc2ncco2)S1(=O)=O)OC1CCOCC1.COc1ccccc1[C@H](CN1c2sc(-c3ncco3)c(C)c2C(=S)N(C(C)(C)C(C)=O)S1(=O)=O)OC(C)C.COc1ccccc1[C@H](Cc1nn(C(C)(C)C(=O)O)c(=O)c2c1nc(-c1ncco1)n2C)OC1CCCCC1.COc1ccccc1[C@H](Cc1nn(C(C)(C)C(N)=O)c(=O)c2c1nc(C1CCC1)n2C)OC1CCCCC1.COc1ccccc1[C@H](Cc1nn(CCS(C)(=O)=O)c(=O)c2c(C)c(-c3ncco3)sc12)OC1CCOCC1.

What is the InChIKey of 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one?

The InChIKey is QWHAWXRVIMHLFW-PPQLDPOVSA-N. The full InChI is InChI=1S/C29H39N5O4.C28H33N5O6.C27H30N6O8S.C27H31N3O7S2.C26H31N3O6S3/c1-29(2,28(30)36)34-27(35)25-24(31-26(33(25)3)18-11-10-12-18)21(32-34)17-23(38-19-13-6-5-7-14-19)20-15-8-9-16-22(20)37-4;1-28(2,27(35)36)33-26(34)23-22(30-24(32(23)3)25-29-14-15-38-25)19(31-33)16-21(39-17-10-6-5-7-11-17)18-12-8-9-13-20(18)37-4;1-31-23-24(30-25(31)26-29-11-16-40-26)33(42(35,36)32(27(23)34)12-7-22-28-10-15-39-22)17-21(41-18-8-13-38-14-9-18)19-5-3-4-6-20(19)37-2;1-17-23-25(38-24(17)26-28-10-14-36-26)20(29-30(27(23)31)11-15-39(3,32)33)16-22(37-18-8-12-35-13-9-18)19-6-4-5-7-21(19)34-2;1-15(2)35-20(18-10-8-9-11-19(18)33-7)14-28-25-21(16(3)22(37-25)23-27-12-13-34-23)24(36)29(38(28,31)32)26(5,6)17(4)30/h8-9,15-16,18-19,23H,5-7,10-14,17H2,1-4H3,(H2,30,36);8-9,12-15,17,21H,5-7,10-11,16H2,1-4H3,(H,35,36);3-6,10-11,15-16,18,21H,7-9,12-14,17H2,1-2H3;4-7,10,14,18,22H,8-9,11-13,15-16H2,1-3H3;8-13,15,20H,14H2,1-7H3/t23-;2*21-;22-;20-/m00000/s1.

What are the key properties of 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one?

2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one has a molecular weight of 2807.34 g/mol, XLogP of 20.51, 47 rotatable bonds, 2 hydrogen bond donors, and 50 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[2-cyclobutyl-7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanamide;2-[7-[(2S)-2-cyclohexyloxy-2-(2-methoxyphenyl)ethyl]-3-methyl-2-(1,3-oxazol-2-yl)-4-oxoimidazo[4,5-d]pyridazin-5-yl]-2-methylpropanoic acid;7-[(2S)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-3-methyl-5-(2-methylsulfonylethyl)-2-(1,3-oxazol-2-yl)thieno[2,3-d]pyridazin-4-one;1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-3-[2-(1,3-oxazol-2-yl)ethyl]-2,2-dioxoimidazo[4,5-c][1,2,6]thiadiazin-4-one;3-[1-[(2R)-2-(2-methoxyphenyl)-2-propan-2-yloxyethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,2-dioxo-4-sulfanylidenethieno[2,3-c][1,2,6]thiadiazin-3-yl]-3-methylbutan-2-one is sourced from PubChem (CID 160536997), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).